Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-05-07 10:28:47
Moss, 7 May 2021
Reference is made to the stock exchange announcement made on 4 May 2021 by
Gentian Diagnostics AS (the "Company") regarding the annual general meeting held
the same date.
The resolutions made by the general meeting, inter alia amendments to the
Company's articles of association, including the conversion of the Company into
a public limited liability company and change of company name have now been
registered with the Norwegian Register of Business Enterprises. The new name of
the Company is Gentian Diagnostics ASA.
For further information, please contact:
Hilja Ibert CEO, Gentian Diagnostics
E-mail: hilja.ibert@gentian.no
Cell Phone: +47 919 05 242
Njaal Kind CFO, Gentian Diagnostics
E-mail: njaal.kind@gentian.no
Cell Phone. +47 919 06 525